COVID-19 Vaccine for the Lowest Income Nations?
Very encouraging news this week: highly scientific research has proved 90 percent efficacy for the Pfizer COVID-19 vaccine. In the coming months this, along with other vaccine prospects, will continue receiving vigorous safety and benefit analysis. Meanwhile, Pfizer anticipates production of roughly 1,5 billion doses of this two-dose vaccine during the next year. Mainstream […]